News Releases

Keyword Search

Date Title
04/11/2024 Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
03/28/2024 Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
03/12/2024 Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
02/28/2024 Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
01/23/2024 Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
01/07/2024 Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
Print Page

Sign-Up for Email Updates

Receive news and updates on Heron’s latest innovations.